Company news
Syntara Limited news in 2019
Syntara Limited's news releases, calls and decks from 2019, newest first.
Pharmaxis Business Plan Update
December 17, 2019
Quarterly Shareholder Update - September 2019
October 30, 2019
FDA Provides Guidance on Bronchitol Approval Steps
October 27, 2019
Pharmaxis Receives $6.2m R&D Tax Incentive
October 16, 2019
Quarterly Shareholder Update - June 2019
July 25, 2019
Pathway to US Bronchitol Approval Clarified in FDA Response
June 19, 2019
US Advisory Committee Positive Recommendation on Bronchitol
May 8, 2019
Quarterly Shareholder Update - March 2019
April 29, 2019
Pharmaxis Commences Phase 1 LOX Clinical Trial
February 21, 2019
Quarterly Shareholder Update - December 2018
January 29, 2019
Pharmaxis Announces LOXL2 Program Phase 2 Ready
January 16, 2019